Prelude Capital Management’s HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 HPX.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,602
Closed -$4K 1787
2022
Q3
$4K Hold
16,602
﹤0.01% 1388
2022
Q2
$1K Hold
16,602
﹤0.01% 1771
2022
Q1
$3K Hold
16,602
﹤0.01% 1721
2021
Q4
$9K Buy
+16,602
New +$11.1K ﹤0.01% 1918

Other funds holding HPX.WS

Prelude Capital Management's HPX.WS Position: Q4 2022 in Review

Prelude Capital Management sold out of HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (HPX.WS) in Q4 2022, closing a stake of 16,602 shares — an estimated $4K sold.

Prelude Capital Management first reported a position in HPX.WS in Q4 2021 and held it in 4 quarters. The position peaked at $9K in Q4 2021. 33 funds tracked by Wall St. Rank hold HPX.WS as of Q4 2022.

  • Prelude Capital Management reported no remaining HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Prelude Capital Management sold 16,602 HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2022, an estimated $4K.
  • Prelude Capital Management first reported a position in HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 4 quarters.
  • Prelude Capital Management's HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $9K in Q4 2021.
  • 33 funds tracked by Wall St. Rank held HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.